← Eichor
Study identifier: NCT07545980 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

CelluJuve® for the Treatment of Moderate to Severe NLFs

Condition: Nasolabial Fold Wrinkles  ·  Sponsor: Spiderwort Biotechnologies Inc.

PhaseNA
Planned participants12
Who can joinAll sexes, 22 Years to no upper limit
Healthy volunteersNo

About this study

Single-center, open-label proof of concept study assessing the safety and effectiveness of CelluJuve® for the treatment of moderate to severe NLFs

This description comes directly from the study's public registry record.

Talk to the study team

Serpil Kucuktepe, PhD  ·  1-866-384-4221  ·  skucuktepe@ethicaclinical.com

Always discuss trial participation with your own doctor first.

Locations (1)

Skin Research Institute LLCCoral Gables, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07545980